What is Mitral Valve Area?
The mitral valve area (MVA) is a measurement of the effective orifice area of the mitral valve, which controls blood flow from the left atrium to the left ventricle. A normal mitral valve area is 4–6 cm². When the valve becomes narrowed (stenotic), the effective orifice area decreases, creating a pressure gradient across the valve and impeding blood flow.
Mitral stenosis is most commonly caused by rheumatic heart disease, which remains prevalent in developing countries. Other causes include mitral annular calcification (common in elderly patients), congenital abnormalities, systemic lupus erythematosus, and carcinoid disease. Accurate measurement of the MVA is critical for determining disease severity, guiding treatment decisions, and timing surgical or percutaneous interventions.
Echocardiography is the primary imaging modality for assessing MVA. Multiple methods exist, each with specific advantages and limitations. Using more than one method and correlating with clinical findings provides the most reliable assessment.
Calculation Methods
1. Continuity Equation
The continuity equation is based on the principle of conservation of mass: blood flow through the left ventricular outflow tract (LVOT) must equal blood flow through the mitral valve (in the absence of regurgitation).
Where LVOTd is the LVOT diameter, LVOTVTI is the velocity-time integral of LVOT flow, and MVVTI is the velocity-time integral of mitral inflow. This method is less dependent on loading conditions but requires accurate LVOT diameter measurement.
2. Pressure Half-Time (PHT) Method
The PHT method, described by Hatle et al. (1979), uses the rate of decline of the transmitral pressure gradient. The pressure half-time is the time required for the peak pressure gradient to decrease to half its initial value.
This is the most widely used method due to its simplicity. The empirical constant 220 was derived from clinical correlations with invasive hemodynamic measurements. However, PHT can be inaccurate in patients with abnormal left atrial or ventricular compliance, aortic regurgitation, or immediately after mitral valvuloplasty.
3. Deceleration Time (DT) Method
The deceleration time method is closely related to the PHT method. The DT is measured from the peak E-wave velocity to the baseline extrapolation of the deceleration slope.
The mathematical relationship between PHT and DT is: PHT = 0.29 × DT. The constant 759 is derived from this relationship (220 / 0.29 ≈ 759).
Severity Classification
| Severity | MVA (cm²) | Mean Gradient (mmHg) | PA Systolic Pressure | Clinical Features |
|---|---|---|---|---|
| Normal | > 4.0 | < 2 | Normal | Asymptomatic |
| Mild Stenosis | 1.5 – 4.0 | < 5 | < 30 mmHg | Usually asymptomatic; may have symptoms with heavy exertion |
| Moderate Stenosis | 1.0 – 1.5 | 5 – 10 | 30 – 50 mmHg | Dyspnea on exertion, fatigue, palpitations |
| Severe Stenosis | < 1.0 | > 10 | > 50 mmHg | Dyspnea at rest, orthopnea, pulmonary edema, atrial fibrillation |
Mitral Valve Anatomy & Stenosis
Rheumatic Heart Disease
Rheumatic heart disease (RHD) is the most common cause of mitral stenosis worldwide. It results from an abnormal immune response to Group A Streptococcal pharyngitis (rheumatic fever), which causes inflammation and progressive fibrosis of the mitral valve leaflets, commissures, and chordae tendineae.
The disease process typically takes 10–20 years from the initial rheumatic fever episode to the development of hemodynamically significant mitral stenosis. RHD affects approximately 33 million people worldwide, predominantly in low- and middle-income countries. The mitral valve is affected in over 90% of RHD cases, either alone or in combination with the aortic valve.
Key pathological features of rheumatic mitral stenosis include:
- Commissural fusion: The most characteristic finding; the valve commissures fuse, reducing the orifice area
- Leaflet thickening: Progressive fibrosis makes the leaflets rigid
- Chordal shortening: The chordae tendineae become thickened and shortened, further restricting valve motion
- Calcification: In advanced stages, calcium deposits further stiffen the valve
Echocardiographic Assessment
A comprehensive echocardiographic evaluation of mitral stenosis includes:
- 2D echocardiography: Direct planimetry of the mitral valve orifice in the parasternal short-axis view (considered the gold standard)
- Doppler assessment: Continuous-wave Doppler across the mitral valve to measure peak and mean pressure gradients
- PHT / DT methods: Calculated from the mitral inflow Doppler profile
- Continuity equation: When other methods are unreliable (e.g., post-valvuloplasty, coexisting aortic regurgitation)
- Wilkins score: Echocardiographic score assessing leaflet mobility, thickening, calcification, and subvalvular disease (used to determine suitability for percutaneous mitral balloon commissurotomy)
| Method | Advantages | Limitations |
|---|---|---|
| Planimetry | Direct measurement; independent of flow and rhythm | Requires good image quality; operator dependent |
| PHT | Simple; reproducible; widely used | Inaccurate with AR, abnormal compliance, post-valvuloplasty |
| Continuity Equation | Independent of loading conditions | Requires accurate LVOT measurement; error-prone with MR |
| DT Method | Related to PHT; simple | Same limitations as PHT |
Worked Examples
Example 1: Pressure Half-Time Method
A patient with mitral stenosis has a PHT of 220 ms:
Example 2: Continuity Equation
LVOT diameter = 2.0 cm, LVOT VTI = 22 cm, MV VTI = 60 cm:
Example 3: Deceleration Time Method
A patient has a mitral E-wave deceleration time of 760 ms:
Frequently Asked Questions
Which method is the most accurate?
Direct planimetry by 2D echocardiography is generally considered the most accurate non-invasive method. Among the Doppler-based methods calculated here, the PHT method is most widely used and validated. However, all methods have limitations, and it is recommended to use multiple methods and correlate with clinical findings for the most accurate assessment.
When is the PHT method unreliable?
The PHT method can be unreliable in the following situations: (1) significant aortic regurgitation (which raises LV diastolic pressure and shortens PHT, overestimating MVA), (2) severely abnormal LV compliance, (3) immediately after percutaneous mitral balloon commissurotomy (PMBC), and (4) atrial septal defect. In these cases, planimetry or the continuity equation should be preferred.
What is the indication for intervention in mitral stenosis?
According to the ACC/AHA guidelines, intervention (percutaneous balloon commissurotomy or surgical valve replacement) is indicated for symptomatic patients with severe mitral stenosis (MVA < 1.5 cm²). Asymptomatic patients with severe stenosis may be considered for intervention if they develop pulmonary hypertension, atrial fibrillation, or hemodynamic compromise during exercise testing.
What is the Wilkins echocardiographic score?
The Wilkins (or Massachusetts General Hospital) score assesses four features of the mitral valve on a scale of 1–4 each: leaflet mobility, leaflet thickening, leaflet calcification, and subvalvular thickening. Total score ranges from 4 to 16. A score of 8 or less is generally considered favorable for percutaneous balloon commissurotomy, with higher success rates and fewer complications.